Evaluation of host QOL and immune function in breast cancer patients with combination of adjuvant chemotherapy and oral administration of Lentinula edodes mycelia extract.
Not Applicable
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000010047
- Lead Sponsor
- Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Pregnant females, possibly pregnant females, females wishing to become pregnant. 2)Nursing mothers. 3)Prior radiotherapy, chemotherapy or hormone therapy. 4)Other patients who are unfit for the study as determined by the attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method QOL(FACT-BRM)
- Secondary Outcome Measures
Name Time Method